These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20946291

  • 21. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK, Lelorier P, Gururaj AV, Monahan KM.
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
    [Abstract] [Full Text] [Related]

  • 22. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
    Blaschke F, Knaus T, Celebi O, Krebs A, Nitardy A, Habedank D, Dietz R, Stockburger M.
    Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
    [Abstract] [Full Text] [Related]

  • 23. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C, Seutter R, Zhu AX, Benditt LC, VanHeel L, Sakaguchi S, Lurie KG, Lu F, Benditt DG.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2258-63. PubMed ID: 16360055
    [Abstract] [Full Text] [Related]

  • 24. Indications and outcome of implantable cardioverter-defibrillators for primary and secondary prophylaxis in patients with noncompaction cardiomyopathy.
    Caliskan K, Szili-Torok T, Theuns DA, Kardos A, Geleijnse ML, Balk AH, van Domburg RT, Jordaens L, Simoons ML.
    J Cardiovasc Electrophysiol; 2011 Aug 20; 22(8):898-904. PubMed ID: 21332865
    [Abstract] [Full Text] [Related]

  • 25. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A, Dokumaci B, Uzun M, Kilicaslan F, Dinckal MH, Yucel O, Karaca M.
    Pacing Clin Electrophysiol; 2005 Jun 20; 28(6):498-505. PubMed ID: 15955181
    [Abstract] [Full Text] [Related]

  • 26. Refractory ventricular fibrillation during bi-ventricular implantable cardioverter defibrillator implantation: a case report of successful cardioversion only with a left ventricular defibrillator lead.
    Chow J, Göbel G, Burger H.
    Europace; 2013 Sep 20; 15(9):1303. PubMed ID: 23537614
    [No Abstract] [Full Text] [Related]

  • 27. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium.
    Sakai Y, Sato Y, Matsuo S, Imai S, Kunimasa T, Matsumoto N, Saito S.
    Int J Cardiol; 2007 May 02; 117(3):e104-6. PubMed ID: 17350119
    [Abstract] [Full Text] [Related]

  • 28. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough?
    Pires LA, Johnson KM.
    J Cardiovasc Electrophysiol; 2006 Feb 02; 17(2):140-5. PubMed ID: 16533250
    [Abstract] [Full Text] [Related]

  • 29. Pacemaker/implantable cardioverter-defibrillator interaction.
    Jimenez A, Dickfeld T, Saliaris A, Shorofsky S.
    Heart Rhythm; 2010 Aug 02; 7(8):1157-60. PubMed ID: 20382269
    [Abstract] [Full Text] [Related]

  • 30. [A case of idiopathic ventricular tachycardia with ventricular fibrillation successfully treated with cryoablations and implantable cardioverter defibrillator].
    Nitta T, Tanaka S, Imura H, Terada K, Ikeshita M, Shoji T.
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Aug 02; 40(8):1279-84. PubMed ID: 1402174
    [Abstract] [Full Text] [Related]

  • 31. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S, Ricci RP, Biscione F, Sgreccia F, Di Belardino N, Rossi P, Giuli S, Grammatico A, De Santo T, Santi E, Merico M, Piccirillo G, Azzolini P, Santini M, Puglisi A.
    Pacing Clin Electrophysiol; 2009 May 02; 32(5):573-8. PubMed ID: 19422577
    [Abstract] [Full Text] [Related]

  • 32. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 33. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 12; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 34. Spectral methods to distinguish ventricular fibrillation from artefact in implantable cardioverter-defibrillators.
    Mollerus ME, Renier C, Lipinski M.
    Europace; 2011 Sep 12; 13(9):1346-51. PubMed ID: 21490037
    [Abstract] [Full Text] [Related]

  • 35. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A, Oreziak A, Lewandowski Z, Hasiec A, Orczykowski M, Walczak F.
    Kardiol Pol; 2010 May 12; 68(5):512-8. PubMed ID: 20491010
    [Abstract] [Full Text] [Related]

  • 36. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B, Lawo T, Zarse M, Lubinski A, Kreutzer U, Mueller J, Schuchert A, Mitzenheim S, Danilovic D, Deneke T, Threshold test using Upper Limit during ImPlantation Study Group.
    Europace; 2008 Aug 12; 10(8):907-13. PubMed ID: 18515789
    [Abstract] [Full Text] [Related]

  • 37. Defibrillation threshold testing and neurologic outcome.
    Karaoğuz R.
    Anadolu Kardiyol Derg; 2007 Jul 12; 7 Suppl 1():47-9. PubMed ID: 17584679
    [Abstract] [Full Text] [Related]

  • 38. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators.
    Lubiński A, Lewicka-Nowak E, Zienciuk A, Królak T, Kempa M, Pazdyga A, Swiatecka G.
    Kardiol Pol; 2005 Apr 12; 62(4):317-28; discussion 329-31. PubMed ID: 15928737
    [Abstract] [Full Text] [Related]

  • 39. [Transvenous subcutaneous implantation technique of the cardioverter/defibrillator].
    Block M, Hammel D, Borggrefe M, Scheld HH, Breithardt G.
    Herz; 1994 Oct 12; 19(5):259-77. PubMed ID: 8001899
    [Abstract] [Full Text] [Related]

  • 40. Using the upper limit of vulnerability to assess defibrillation efficacy at implantation of ICDs.
    Swerdlow CD, Shehata M, Chen PS.
    Pacing Clin Electrophysiol; 2007 Feb 12; 30(2):258-70. PubMed ID: 17338725
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.